ReferenceID 6146

Rhynchophylline promotes stem cell autonomous metabolic homeostasis

Cytotherapy

Rhynchophylline (Rhy) effectively obstructs the expansive signaling pathways of degenerative diseases, including Alzheimer disease, Parkinson disease, epilepsy and amyotrophic lateral sclerosis, and stimulates neurogenes

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final reference record.

Reference Id
6146
Evidence Id
22736
Core Evidence Id
22736
Source Reference Id
5554
Herb2 Reference Id
HBREF006351
Subject Paper Key
HBIN042297_31983606
Pubmed Id
31983606
Doi
10.1016/j.jcyt.2019.12.008
Paper Title
Rhynchophylline promotes stem cell autonomous metabolic homeostasis
Paper Abstract
Rhynchophylline (Rhy) effectively obstructs the expansive signaling pathways of degenerative diseases, including Alzheimer disease, Parkinson disease, epilepsy and amyotrophic lateral sclerosis, and stimulates neurogenesis. Maintenance of stemness and cell proliferation requires sophisticated intracellular environments to achieve pluripotency via specific expression of genes and proteins. We examined whether Rhy promotes this regulation in bone marrow human mesenchymal stromal cells (BM-hMSCs). Results revealed (i) Rhy modulated biological activity by regulating the mitochondria, N-methyl-D-aspartate receptor subunit, and levels of FGFbeta (basic fibroblast growth factor), BDNF (brain-derived neurotrophic factor), OXTR (oxytocin receptor) and ATP (Adenosine triphosphate); (ii) Rhy altered expression level of BM-MSC proliferation/differentiation-related transcription genes; and (iii) interestingly, Rhy amplified the glycolytic flow ratio and lactate dehydrogenase activity while reducing pyruvate dehydrogenase activity, indicating a BM-hMSC metabolic shift of mitochondrial oxidative phosphorylation into aerobic glycolysis. Altogether, we demonstrated a novel mechanism of action for Rhy-induced BM-hMSC modification, which can enhance the cell transplantation approach by amplifying the metabolic activity of stem cells.
Journal
Cytotherapy
Publish Year
2020
Experiment Subject
human; bone marrow human mesenchymal stromal cells
Experiment Type
Cell Experiment
Phenotype Related
Parkinson Disease; Amyotrophic Lateral Sclerosis; Epilepsy; Alzheimer Disease; Degenerative Diseases; Rhynchophylline
Paper Title Cn
Paper Title En
Rhynchophylline promotes stem cell autonomous metabolic homeostasis
Bilingual Status
semi_complete